Search Results - "Polinsky, M."

Long‐Term Outcomes in Belatacept‐ Versus Cyclosporine‐Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT‐EXT, a Phase III Randomized Study by Durrbach, A., Pestana, J. M., Florman, S., Carmen Rial, M., Rostaing, L., Kuypers, D., Matas, A., Wekerle, T., Polinsky, M., Meier‐Kriesche, H. U., Munier, S., Grinyó, J. M.

“…In the Belatacept Evaluation of Nephroprotection and Efficacy as First‐Line Immunosuppression Trial–Extended Criteria Donors (BENEFIT‐EXT), extended criteria…”
Get full text

De novo donor‐specific antibodies in belatacept‐treated vs cyclosporine‐treated kidney‐transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT‐EXT studies by Bray, R. A., Gebel, H. M., Townsend, R., Roberts, M. E., Polinsky, M., Yang, L., Meier‐Kriesche, H.‐U., Larsen, C. P.

“…Donor‐specific antibodies (DSAs) are associated with an increased risk of antibody‐mediated rejection and graft failure. In BENEFIT and BENEFIT‐EXT,…”
Get full text

Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT by Bray, R. A., Gebel, H. M., Townsend, R., Roberts, M. E., Polinsky, M., Yang, L., Meier‐Kriesche, H.‐U., Larsen, C. P.

“…BENEFIT and BENEFIT‐EXT were phase III studies of cytotoxic T‐cell crossmatch–negative kidney transplant recipients randomized to belatacept more intense…”
Get full text

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly by Vincenti, F., Blancho, G., Durrbach, A., Grannas, G., Grinyó, J., Meier‐Kriesche, H.‐U., Polinsky, M., Yang, L., Larsen, C. P.

“…In the phase II IM103‐100 study, kidney transplant recipients were first randomized to belatacept more‐intensive‐based (n = 74), belatacept…”
Get full text

Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials by Demopoulos, L, Polinsky, M, Steele, G, Mines, D, Blum, M, Caulfield, M, Adamkovic, A, Liu, Q, Harler, M.B, Hahn, C, Singh, A

“…Abstract Introduction Cytomegalovirus (CMV) is an opportunistic infection that causes substantial morbidity and mortality in transplant recipients. This pooled…”
Get full text

Breast cancer survivors : psychosocial concerns and quality of life by GANZ, P. A, COSCARELLI, A, FRED, C, KAHN, B, POLINSKY, M. L, PETERSEN, L

“…To describe the psychosocial concerns and quality of life of breast cancer survivors evaluated 2 and 3 years after primary treatment. A sample of 139 breast…”
Get full text

Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency by Gupta, M, Polinsky, M, Senephansiri, H, Snead, O.C, Jansen, E.E.W, Jakobs, C, Gibson, K.M

“…Mice with targeted deletion of the GABA catabolic enzyme succinic semialdehyde dehydrogenase (SSADH) manifest lethal tonic–clonic seizures, amenable to…”
Get full text

Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants by Roberts, Sigrid C, Tancer, Michael J, Polinsky, Michelle R, Gibson, K Michael, Heby, Olle, Ullman, Buddy

“…The polyamine pathway of protozoan parasites has been successfully targeted in anti-parasitic therapies and is significantly different from that of the…”
Get full text

Characteristics of women at risk for psychosocial distress in the year after breast cancer by Schag, C A, Ganz, P A, Polinsky, M L, Fred, C, Hirji, K, Petersen, L

“…To provide a detailed description of rehabilitation problems of women, considered to be low risk and at risk for psychosocial morbidity, diagnosed with stage I…”
Get more information

Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients by SILVERSTEIN, D. M, PALMER, J, POLINSKY, M. S, BRAAS, C, CONLEY, S. B, BALUARTE, H. J

“…Hyperlipidemia (HL) is a common problem in adult renal transplant (TP) recipients, contributing to an increased risk of cardiovascular disease and chronic TP…”
Get full text

Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection by BUTANI, L, PALMER, J, BALUARTE, H. J, POLINSKY, M. S

“…Mycophenolate mofetil (MMF) has been shown to be superior to azathioprine in reducing the incidence of acute rejection in adult renal transplant recipients…”
Get full text

Functional Status of Long-Term Breast Cancer Survivors: Demonstrating Chronicity by Polinsky, Margaret L

“…Surveyed 223 breast cancer survivors 16 months to 32 years from original surgery to assess their current physical, psychological, and social functional status…”
Get full text

Resistance to Drug Abuse Treatment: A Comparison of Drug Users Who Accept or Decline Treatment Referral Assessment by Boyle, Kathleen, Polinsky, Margaret L., Hser, Yih-Ing

“…Many drug abusers do not seek help in formal treatment settings, and little is known about their resistance to treatment. In this study, we offered a treatment…”
Get full text

Safety and efficacy of corticosteroids in childhood nephrotic syndrome with concomitant hepatitis B by Butani, L, Polinsky, M S

Get full text

Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? by Ganz, P A, Schag, A C, Lee, J J, Polinsky, M L, Tan, S J

“…Women with a breast cancer diagnosis often are given a choice between breast conservation or mastectomy as the primary treatment for their cancer. Despite the…”
Get more information

Response to the varicella vaccine in children with nephrotic syndrome by Quien, Ramcel M., Kaiser, Bruce A., Deforest, Adamadia, Polinsky, Martin S., Fisher, Meg, Baluarte, H.J.

“…Varicella vaccine was administered to seven children with corticosteroid-sensitive nephrotic syndrome. Immunization was not associated with any significant…”
Get full text

Use of calcium-channel blockers in pediatric renal transplant recipients by Silverstein, Douglas M., Palmer, JoAnn, Baluarte, H. Jorge, Brass, Caroline, Conley, Susan B., Polinsky, Martin S.

“…: Hypertension (HTN) is a significant problem in pediatric renal transplant (TP) recipients, predisposing the individuals to the development of cardiovascular…”
Get full text

Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial by ALBERU, Josefina, PASCOE, Michael D, CAMPISTOL, Josep M, SCHENA, Francesco P, DEL CARMEN RIAL, Maria, POLINSKY, Martin, NEYLAN, John F, KORTH-BRADLEY, Joan, GOLDBERG-ALBERTS, Robert, MALLER, Eric S

“…Long-term immunosuppression imposes increased malignancy risk in renal allograft recipients, significantly contributing to overall morbidity and mortality…”
Get full text

Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer by Ganz, P A, Lee, J J, Sim, M S, Polinsky, M L, Schag, C A

“…This paper explores the relationship between age, psychosocial status and quality of life in a community based sample (n = 229) of newly-diagnosed breast…”
Get more information

Predictive value of race in post-transplantation recurrence of focal segmental glomerulosclerosis in children by BUTANI, L, POLINSKY, M. S, KAISER, B. A, BALUARTE, H. J

“…Focal segmental glomerulosclerosis (FSGS) is a leading cause of end-stage renal disease (ESRD) in children, and one of the most difficult to manage because of…”
Get full text